Antifungal step-down therapy based on hospital intravenous to oral switch policy and susceptibility testing in adult patients with candidaemia: a single centre experience.
about
Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data.Characteristics and outcomes of anti-infective de-escalation during health care-associated intra-abdominal infectionsAntifungal stewardship considerations for adults and pediatrics.Echinocandin to fluconazole step-down therapy in critically ill patients with invasive, susceptible Candida albicans infections.De-escalation of antifungal treatment in critically ill patients with suspected invasive Candida infection: incidence, associated factors, and safety.
P2860
Antifungal step-down therapy based on hospital intravenous to oral switch policy and susceptibility testing in adult patients with candidaemia: a single centre experience.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Antifungal step-down therapy b ...... a: a single centre experience.
@en
Antifungal step-down therapy b ...... a: a single centre experience.
@nl
type
label
Antifungal step-down therapy b ...... a: a single centre experience.
@en
Antifungal step-down therapy b ...... a: a single centre experience.
@nl
prefLabel
Antifungal step-down therapy b ...... a: a single centre experience.
@en
Antifungal step-down therapy b ...... a: a single centre experience.
@nl
P2093
P2860
P356
P1476
Antifungal step-down therapy b ...... a: a single centre experience.
@en
P2093
P2860
P356
10.1111/IJCP.12231
P577
2014-01-01T00:00:00Z